Ecuador vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Ecuador
100.0%
in 2024
Sur
82.0%
in 2024
Ecuador rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ecuador
- Sur
How they compare
Ecuador currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Ecuador's figure about 1.2 times Sur's.
Across all 16 years both countries report, Ecuador has been ahead every year.
Ecuador ranks 1st and Sur ranks 2nd of 144 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 41.0% | 59.0% | Ecuador |
| 2010s | 95.8% | 67.6% | 28.2% | Ecuador |
| 2020s | 93.8% | 75.8% | 18.0% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ecuador or Sur?
- Ecuador, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ecuador and Sur?
- 18.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Sur?
- 16 years are reported by both, from 2008 to 2024.
- How do Ecuador and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ecuador ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.